Search results for "trials"

showing 10 items of 966 documents

Adaptive trial design: a general methodology for censored time to event data.

2008

Adaptive designs allow a clinical trial design to be changed according to interim findings without inflating type I error. The Inverse Normal method can be considered as an adaptive generalization of classical group sequential designs. The use of the Inverse Normal method for censored survival data was demonstrated only for the logrank statistic. However, the logrank statistic is inefficient in the presence of nuisance covariates affecting survival. We demonstrate, how the Inverse Normal method can be applied to Cox regression analysis. The required independence between test statistics of the different stages of the trial can be obtained by two different approaches. One is using the indepen…

Clinical Trials as Topicbusiness.industryProportional hazards modelNormal DistributionRegression analysisGeneral MedicineSurvival AnalysisTimeNormal distributionResearch DesignData Interpretation StatisticalStatisticsCovariateEconometricsMedicineHumansPharmacology (medical)Computer SimulationbusinessStatisticIndependence (probability theory)Statistical hypothesis testingType I and type II errorsProportional Hazards ModelsRandomized Controlled Trials as TopicContemporary clinical trials
researchProduct

Thoughts of a reviewer

1990

Clinical Trials as Topicmedicine.medical_specialtyResearch Designbusiness.industryResearchWritingFamily medicinePediatrics Perinatology and Child HealthHumansMedicinebusinessRandomized Controlled Trials as TopicEuropean Journal of Pediatrics
researchProduct

Oral Glycoprotein IIb/IIa Antagonists for Unstable Angina — Is There Still a Chance for the Oral Substances?

2001

The intravenous glycoprotein IIb/IIIa antagonists abciximab, tirofiban and eptifibatide are well accepted for the therapy of patients with unstable angina and/or as concomitant medication during coronary interventions. Despite the fact that these drugs are not used in all patients presenting with unstable angina during coronary interventions, the scientific evidence is overwhelming including the substantial reduction in mortality 3 years after utilisation of abciximab for coronary interventions in patients with unstable angina. In addition to these two indications, intravenous glycoprotein IIb/IIIa antagonists are currently being investigated for use in patients undergoing carotid artery in…

Clinical Trials as Topicmedicine.medical_specialtyUnstable anginaFibrinogen receptorbusiness.industryAdministration OralPlatelet Glycoprotein GPIIb-IIIa ComplexHematologyTirofibanmedicine.diseaseAnginaInternal medicinemedicineAbciximabCardiologyEptifibatideHumansAngina UnstableMyocardial infarctionbusinessStrokePlatelet Aggregation Inhibitorsmedicine.drugThrombosis Research
researchProduct

Possible clinical usefulness of embryonic stem cells

2012

Abstract Are embryonic stem cells being used for therapeutic purposes? The aim of this short report is to review to what extent are embryonic stem cells currently used for therapeutic purposes. To the best of our knowledge, only four clinical trials have been authorised so far to use human embryonic stem cells for therapeutic purposes; two of these are included in the ClinicalTrials.gov data base, and the other two, the study sponsored by Geron and the last one initiated by Advanced Cell Technology in the United Kingdom, are not. But, in addition, Geron withdrew the clinical trial which had been originally proposed by the company itself. This brief review focuses the debate on the use of em…

Clinical Trials as Topicmedicine.medical_specialtybusiness.industryGeneral MedicineHuman cellStem Cell ResearchCell technologyEmbryonic stem cellUnited StatesClinical trialMacular DegenerationHumansmedia_common.cataloged_instanceMedicineEuropean UnionEuropean unionbusinessIntensive care medicineEmbryonic Stem Cellsmedia_commonRevista Clínica Española
researchProduct

Almotriptan: meeting today’s needs in acute migraine treatment

2007

Migraine is a common disorder associated with considerable individual and economic burden. Triptans are recommended for the treatment of migraine of any severity in patients who have failed to gain adequate relief with nonspecific medication; early transition to triptans avoids prolonged morbidity in patients failing to respond to nonspecific medications. There is evidence that early intervention therapy with oral formulations in migraine, soon after the onset of an attack and when pain is still mild, improves efficacy. Seven different triptans are currently marketed, with differing pharmacologic, efficacy and tolerability profiles. Almotriptan has many positive features, which include rigo…

Clinical Trials as Topicmedicine.medical_specialtybusiness.industryMigraine DisordersGeneral NeurosciencePsychological interventionTriptansEarly TherapyPlacebomedicine.diseaseTryptaminesSerotonin Receptor AgonistsSumatriptanTolerabilityMigraineAlmotriptanmedicinePhysical therapyHumansPharmacology (medical)Neurology (clinical)Intensive care medicinebusinessmedicine.drugExpert Review of Neurotherapeutics
researchProduct

Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study.

2015

Summary Background Molybdenum cofactor deficiency (MoCD) is characterised by early, rapidly progressive postnatal encephalopathy and intractable seizures, leading to severe disability and early death. Previous treatment attempts have been unsuccessful. After a pioneering single treatment we now report the outcome of the complete first cohort of patients receiving substitution treatment with cyclic pyranopterin monophosphate (cPMP), a biosynthetic precursor of the cofactor. Methods In this observational prospective cohort study, newborn babies with clinical and biochemical evidence of MoCD were admitted to a compassionate-use programme at the request of their treating physicians. Intravenous…

Compassionate Use TrialsMalePediatricsmedicine.medical_specialtyGENOMIC STRUCTUREFEATURESEncephalopathyMolybdopterin synthaseCyclic pyranopterin monophosphateDrug Administration ScheduleCohort Studieschemistry.chemical_compoundOrganophosphorus CompoundsmedicineURINEHumansBIOSYNTHESISProspective cohort studyAdverse effectMolybdenum cofactor deficiencyPRECURSORMetal Metabolism Inborn ErrorsMetal metabolismbusiness.industryMUTATIONSInfant NewbornGENES MOCS1CPMPMOLYBDOPTERIN SYNTHASEGeneral Medicinemedicine.diseasePterinsTreatment OutcomechemistryFemalebusinessCohort studyLancet (London, England)
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review wi…

2017

Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed psychiatric disorders in childhood. A wide variety of treatments have been used for the management of ADHD. We aimed to compare the efficacy and safety of pharmacological, psychological and complementary and alternative medicine interventions for the treatment of ADHD in children and adolescents. Methods and findings We performed a systematic review with network meta-analyses. Randomised controlled trials (≥ 3 weeks follow-up) were identified from published and unpublished sources through searches in PubMed and the Cochrane Library (up to April 7, 2016). Interventions of interest were pharmacolo…

Complementary TherapiesMaleTrastorns de l'atencióPoison controllcsh:MedicineMathematical and Statistical Techniques0302 clinical medicineBehavior TherapyMedicine and Health SciencesMedicine030212 general & internal medicineChildlcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinaryPharmaceuticsMethylphenidate3. Good healthGuanfacineAntidepressant Drug TherapyNeurologyTolerabilityBehavioral PharmacologyResearch DesignPhysical SciencesFemaleStatistics (Mathematics)Research Articlemedicine.drugNeurological Drug Therapymedicine.medical_specialtyAdolescentClinical Research DesignNeuropsychiatric DisordersResearch and Analysis MethodsPlacebo03 medical and health sciencesDevelopmental NeuroscienceDrug TherapyInternal medicineMental Health and PsychiatryHumansAttention deficit hyperactivity disorderPsiquiatriaStatistical MethodsAdverse effectPsychiatryPharmacologyBehaviorbusiness.industryAtomoxetinelcsh:RCentral Nervous System DepressantsBiology and Life Sciencesmedicine.diseaseAttention Deficit Disorder with HyperactivityNeurodevelopmental DisordersCentral Nervous System StimulantsAdhdlcsh:QAdverse EventsbusinessMental Health TherapiesMathematics030217 neurology & neurosurgeryNeuroscienceMeta-AnalysisPLoS ONE
researchProduct

Effects of self-myofascial release: A systematic review.

2015

Summary Background Self-myofascial release (SMFR) is a type of myofascial release performed by the individual themselves rather than by a clinician, typically using a tool. Objectives To review the literature regarding studies exploring acute and chronic clinical effects of SMFR. Methods PubMed and Google Scholar databases were searched during February 2015 for studies containing words related to the topic of SMFR. Results Acutely, SMFR seems to increase flexibility and reduce muscle soreness but does not impede athletic performance. It may lead to improved arterial function, improved vascular endothelial function, and increased parasympathetic nervous system activity acutely, which could b…

Complementary and Manual Therapymyalgiamedicine.medical_specialtyPopulationPhysical Therapy Sports Therapy and RehabilitationAthletic PerformanceAutonomic Nervous SystemPhysical medicine and rehabilitationVascular StiffnessDelayed onset muscle sorenessmedicineHumanseducationMuscle SkeletalTherapy Soft TissueRandomized Controlled Trials as Topiceducation.field_of_studybiologyAthletesbusiness.industryRehabilitationFlexibility (personality)Myalgiabiology.organism_classificationMyofascial releaseBiomechanical PhenomenaAutonomic nervous systemComplementary and alternative medicinePhysical therapyFoam rollingEndothelium Vascularmedicine.symptombusinessJournal of bodywork and movement therapies
researchProduct

Clinically-Driven Virtual Patient Cohorts Generation: An Application to Aorta

2021

The combination of machine learning methods together with computational modeling and simulation of the cardiovascular system brings the possibility of obtaining very valuable information about new therapies or clinical devices through in-silico experiments. However, the application of machine learning methods demands access to large cohorts of patients. As an alternative to medical data acquisition and processing, which often requires some degree of manual intervention, the generation of virtual cohorts made of synthetic patients can be automated. However, the generation of a synthetic sample can still be computationally demanding to guarantee that it is clinically meaningful and that it re…

Computer sciencePhysiologySample (statistics)Target populationMachine learningcomputer.software_genreData acquisitionVirtual patientPhysiology (medical)digital twinQP1-981support vector machineOriginal Researchbusiness.industrygenerative adversarial networkSampling (statistics)synthetic populationthoracic-aortaSupport vector machineReference samplein-silico trialsCohortArtificial intelligencevirtual cohortbusinesscomputerclinically-driven samplingFrontiers in Physiology
researchProduct

GPU-Based Occlusion Minimisation for Optimal Placement of Multiple 3D Cameras

2020

This paper presents a fast GPU-based solution to the 3D occlusion detection problem and the 3D camera placement optimisation problem. Occlusion detection is incorporated into the optimisation problem to return near-optimal positions for 3D cameras in environments containing occluding objects, which maximises the volume that is visible to the cameras. In addition, the authors’ previous work on 3D sensor placement optimisation is extended to include a model for a pyramid-shaped viewing frustum and to take the camera’s pose into account when computing the optimal position.

Computer sciencebusiness.industry010401 analytical chemistryComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION020207 software engineering02 engineering and technology01 natural sciencesMinimisation (clinical trials)0104 chemical sciencesCUDAViewing frustumOcclusion0202 electrical engineering electronic engineering information engineeringComputer visionArtificial intelligencebusinessComputingMethodologies_COMPUTERGRAPHICS2020 15th IEEE Conference on Industrial Electronics and Applications (ICIEA)
researchProduct